메뉴 건너뛰기




Volumn 30, Issue 2, 2008, Pages 227-232

Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients

Author keywords

Chronic renal failure; Dialysis; Efficacy; Hepatitis C; Pegylated interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2A;

EID: 39749157615     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701813368     Document Type: Article
Times cited : (15)

References (34)
  • 1
    • 0347694845 scopus 로고    scopus 로고
    • Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients
    • Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18:1071-1081.
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 1071-1081
    • Fabrizi, F.1    Dulai, G.2    Dixit, V.3    Bunnapradist, S.4    Martin, P.5
  • 2
    • 0034527627 scopus 로고    scopus 로고
    • Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives
    • Fabrizi F, Martin P, Lunghi G, Ponticelli C. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives. Int J Artif Organs. 2000;23:805-816.
    • (2000) Int J Artif Organs , vol.23 , pp. 805-816
    • Fabrizi, F.1    Martin, P.2    Lunghi, G.3    Ponticelli, C.4
  • 3
    • 4444232172 scopus 로고    scopus 로고
    • Hepatitis C infection associated with renal disease and chronic renal failure
    • Poordad FF, Fabrizi F, Martin P. Hepatitis C infection associated with renal disease and chronic renal failure. Semin Liver Dis. 2004;24:69-77.
    • (2004) Semin Liver Dis , vol.24 , pp. 69-77
    • Poordad, F.F.1    Fabrizi, F.2    Martin, P.3
  • 4
    • 33645023956 scopus 로고    scopus 로고
    • Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes
    • Bozdayi G, Rota S, Verdi H, Derici U, Sindel S. Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes. Bull Microbiol. 2002;36:247-252.
    • (2002) Bull Microbiol , vol.36 , pp. 247-252
    • Bozdayi, G.1    Rota, S.2    Verdi, H.3    Derici, U.4    Sindel, S.5
  • 6
    • 0036295526 scopus 로고    scopus 로고
    • Hepatitis C infection and the patient with end-stage renal disease
    • Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36:3-10.
    • (2002) Hepatology , vol.36 , pp. 3-10
    • Fabrizi, F.1    Poordad, F.2    Martin, P.3
  • 7
    • 39749118170 scopus 로고    scopus 로고
    • National Institutes of Health. Management of Hepatitis C: 2002. National Institutes of Health consensus development conference statement. Hepatology. 2002;36(Suppl. 1):3-20.
    • National Institutes of Health. Management of Hepatitis C: 2002. National Institutes of Health consensus development conference statement. Hepatology. 2002;36(Suppl. 1):3-20.
  • 8
    • 39749105502 scopus 로고    scopus 로고
    • Advances in HCV Treatment: 2006
    • American Association for the Study of Liver Diseases, October 27-31, Boston, Massachusetts. Available from:, Accessed July 2, 2007
    • American Association for the Study of Liver Diseases. Advances in HCV Treatment: 2006. 2006 Annual Meeting, October 27-31, 2006, Boston, Massachusetts. Available from: http://clinicaloptions.com/Hepatitis/ Conference%20Coverage/Boston%202006/Tracks/HCV%20Treatment.aspx. Accessed July 2, 2007.
    • (2006) 2006 Annual Meeting
  • 9
    • 33645022095 scopus 로고    scopus 로고
    • Renal transplantation in chronic hepatitis
    • Gane E. Renal transplantation in chronic hepatitis. J Gastroenterol Hepatol. 2004;19:99-102.
    • (2004) J Gastroenterol Hepatol , vol.19 , pp. 99-102
    • Gane, E.1
  • 10
    • 1442308277 scopus 로고    scopus 로고
    • Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well?
    • Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well? Ann Intern Med. 2004;140:370-381.
    • (2004) Ann Intern Med , vol.140 , pp. 370-381
    • Zeuzem, S.1
  • 11
    • 0035985388 scopus 로고    scopus 로고
    • Recent advances in the management of hepatitis C in the dialysis population
    • Fabrizi F, Lunghi G, Martin P. Recent advances in the management of hepatitis C in the dialysis population. Int J Artif Organs. 2002;25:503-511.
    • (2002) Int J Artif Organs , vol.25 , pp. 503-511
    • Fabrizi, F.1    Lunghi, G.2    Martin, P.3
  • 12
    • 0031593545 scopus 로고    scopus 로고
    • Pharmacokinetics of alpha-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications
    • Rostaing L, Chatelut E, Payen JL, et al. Pharmacokinetics of alpha-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications. J Am Soc Nephrol. 1998;9:2344-2348.
    • (1998) J Am Soc Nephrol , vol.9 , pp. 2344-2348
    • Rostaing, L.1    Chatelut, E.2    Payen, J.L.3
  • 13
    • 33645034186 scopus 로고    scopus 로고
    • Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C
    • Kokoglu OF, Ucmak H, Hosoglu S, et al. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol. 2006;21:575-580.
    • (2006) J Gastroenterol Hepatol , vol.21 , pp. 575-580
    • Kokoglu, O.F.1    Ucmak, H.2    Hosoglu, S.3
  • 14
    • 34748874598 scopus 로고    scopus 로고
    • The kidney transplant recipient with hepatitis c infection: Pre- and posttransplantation treatment
    • Terrault NA, Adey DB. The kidney transplant recipient with hepatitis c infection: Pre- and posttransplantation treatment. Clin J Am Soc Nephrol. 2007;2:563-575.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 563-575
    • Terrault, N.A.1    Adey, D.B.2
  • 15
    • 8444237788 scopus 로고    scopus 로고
    • Treatment of chronic viral hepatitis in patients with renal disease
    • Fabrizi F, Martin P, Bunnapradist S. Treatment of chronic viral hepatitis in patients with renal disease. Gastroenterol Clin North Am. 2004;33:655-670.
    • (2004) Gastroenterol Clin North Am , vol.33 , pp. 655-670
    • Fabrizi, F.1    Martin, P.2    Bunnapradist, S.3
  • 16
    • 0041317671 scopus 로고    scopus 로고
    • Pharmacokinetics of peginterferons
    • l, 23-28
    • Zeuzem S, Welsch C, Herrmann E. Pharmacokinetics of peginterferons. Semin Liver Dis. 2003;23 (Suppl. l.):23-28.
    • (2003) Semin Liver Dis , vol.23 , Issue.SUPPL.
    • Zeuzem, S.1    Welsch, C.2    Herrmann, E.3
  • 17
    • 33748592811 scopus 로고    scopus 로고
    • Pegylated-interferon alpha 2a treatment for chronic hepatitis C patients on chronic hemodialysis
    • Sporea I, Popescu A, Sirli R, et al. Pegylated-interferon alpha 2a treatment for chronic hepatitis C patients on chronic hemodialysis. World J Gastroenterol. 2006;12:4191-4194.
    • (2006) World J Gastroenterol , vol.12 , pp. 4191-4194
    • Sporea, I.1    Popescu, A.2    Sirli, R.3
  • 18
    • 33846999883 scopus 로고    scopus 로고
    • Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection
    • Chan TM, Ho SK, Tang CS, Tse KC, Lam MF, Lai KN, Yung S. Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection. Nephrology. 2007;12:11-17.
    • (2007) Nephrology , vol.12 , pp. 11-17
    • Chan, T.M.1    Ho, S.K.2    Tang, C.S.3    Tse, K.C.4    Lam, M.F.5    Lai, K.N.6    Yung, S.7
  • 19
    • 3142702669 scopus 로고    scopus 로고
    • Pegylated interferon-alpha 2b monotherapy for hemodialysis patients with chronic hepatitis C
    • Annicchiarico BE, Siciliano M. Pegylated interferon-alpha 2b monotherapy for hemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther. 2004;20:123-124.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 123-124
    • Annicchiarico, B.E.1    Siciliano, M.2
  • 20
    • 31544438279 scopus 로고    scopus 로고
    • Randomized trial of pegylated interferon alpha-2b monotherapy in hemodialysis patients with chronic hepatitis C
    • Russo MW, Ghalib R, Sigal S, Joshi V. Randomized trial of pegylated interferon alpha-2b monotherapy in hemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant. 2006;21:437-443.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 437-443
    • Russo, M.W.1    Ghalib, R.2    Sigal, S.3    Joshi, V.4
  • 21
    • 14944368258 scopus 로고    scopus 로고
    • Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?
    • Potthoff A, Wiegand J, Luth JB, Wedemeyer H, Manns MP, Tillmann HL. Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C? Clin Nephrol. 2005;63:232-235.
    • (2005) Clin Nephrol , vol.63 , pp. 232-235
    • Potthoff, A.1    Wiegand, J.2    Luth, J.B.3    Wedemeyer, H.4    Manns, M.P.5    Tillmann, H.L.6
  • 23
    • 33947274748 scopus 로고    scopus 로고
    • Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: Results from a large, multicenter audit
    • Covic A, Maftei ID, Mardare NG, et al. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: Results from a large, multicenter audit. J Nephrol. 2006;19:794-801.
    • (2006) J Nephrol , vol.19 , pp. 794-801
    • Covic, A.1    Maftei, I.D.2    Mardare, N.G.3
  • 25
    • 0037299204 scopus 로고    scopus 로고
    • Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype Ib and high virus load
    • Arase Y, Ikeda K, Tsubota A, et al. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype Ib and high virus load. J Gastroenterol. 2003;2:158-163.
    • (2003) J Gastroenterol , vol.2 , pp. 158-163
    • Arase, Y.1    Ikeda, K.2    Tsubota, A.3
  • 26
    • 9744247626 scopus 로고    scopus 로고
    • Current treatment for chronic hepatitis C
    • Ferenci P. Current treatment for chronic hepatitis C. Curr Treat Options Gastroenterol. 2004;7:491-499.
    • (2004) Curr Treat Options Gastroenterol , vol.7 , pp. 491-499
    • Ferenci, P.1
  • 27
    • 0141459375 scopus 로고    scopus 로고
    • Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study
    • Watanabe H, Saito T, Shinzawa H, et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A population-based cohort study. J Med Virol. 2003;71:56-61.
    • (2003) J Med Virol , vol.71 , pp. 56-61
    • Watanabe, H.1    Saito, T.2    Shinzawa, H.3
  • 28
    • 0036102602 scopus 로고    scopus 로고
    • Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population
    • Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut. 2002;50:693-696.
    • (2002) Gut , vol.50 , pp. 693-696
    • Kondili, L.A.1    Chionne, P.2    Costantino, A.3
  • 29
    • 0037784059 scopus 로고    scopus 로고
    • Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance
    • Mazzeo C, Azzaroli F, Giovanelli S, et al. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut. 2003;52:1030-1034.
    • (2003) Gut , vol.52 , pp. 1030-1034
    • Mazzeo, C.1    Azzaroli, F.2    Giovanelli, S.3
  • 30
    • 0036829817 scopus 로고    scopus 로고
    • Use and interpretation of virological tests for hepatitis C
    • Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36:65-73.
    • (2002) Hepatology , vol.36 , pp. 65-73
    • Pawlotsky, J.M.1
  • 31
    • 0028805250 scopus 로고
    • Interferonalpha 2b treatment of chronic hepatitis C in hemodialysis patients
    • Raptopoulou-Gigi M, Spaia S, Garifallos A, et al. Interferonalpha 2b treatment of chronic hepatitis C in hemodialysis patients. Nephrol Dial Transplant. 1995;10:1834-1837.
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 1834-1837
    • Raptopoulou-Gigi, M.1    Spaia, S.2    Garifallos, A.3
  • 32
    • 0031091154 scopus 로고    scopus 로고
    • A double-blind controlled trial of recombinant interferon-alpha 2b in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels
    • Fernandez JL, Rendo P, del Pino N. A double-blind controlled trial of recombinant interferon-alpha 2b in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. J Viral Hepatitis. 1997;4:113-119.
    • (1997) J Viral Hepatitis , vol.4 , pp. 113-119
    • Fernandez, J.L.1    Rendo, P.2    del Pino, N.3
  • 33
    • 0030661749 scopus 로고    scopus 로고
    • High rate of hepatitis C virus clearance in hemodialysis patients after interferonalpha therapy
    • Izopet J, Rostaing L, Moussion F, et al. High rate of hepatitis C virus clearance in hemodialysis patients after interferonalpha therapy. J Infect Dis. 1997;176:1614-1617.
    • (1997) J Infect Dis , vol.176 , pp. 1614-1617
    • Izopet, J.1    Rostaing, L.2    Moussion, F.3
  • 34
    • 0033281416 scopus 로고    scopus 로고
    • Efficacy and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C virus infection in hemodialysis patients. Pre- and post-renal transplantation assessment
    • Campistol JM, Esforzado N, Martinez J, et al. Efficacy and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C virus infection in hemodialysis patients. Pre- and post-renal transplantation assessment. Nephrol Dial Transplant. 1999;14:2704-2709.
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 2704-2709
    • Campistol, J.M.1    Esforzado, N.2    Martinez, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.